The following hospital and health system executive moves happened in the past week, beginning with the most recent.
Leadership & Management
Franklin, Tenn.-based M*Modal has announced enhancements to its iOS mobility dictation solution.
The U.S. Food and Drug Administration has approved the first fully implantable neurostimulator as a treatment for obstructive sleep apnea, according to a news release by Minneapolis-based Inspire Medical Systems, the manufacturer of the device.
Johnson & Johnson has suspended sales of its laparoscopic power morcellators worldwide, according to a Medscape report.
With increased efforts to crack down on infection rates and improve infection control and prevention, infection control companies are increasingly seeing the need for innovative solutions. Here, Lynda Lurie, associate director of marketing for Clorox Healthcare, comments on innovations in…
Advertisement
Sunnyvale, Calif.-based Accuracy and Irving, Texas-based Novation have signed a three-year contract, in which Accuracy will provide its CyberKnife M6 and TomoTherapy H radiation therapy products to Novation members.
The ophthalmology diagnostics and surgical devices market is expected to reach $40.38 billion by 2019, growing at a compound annual growth rate of 6.6 percent, according to a Transparency Market Research report.
Irving, Texas-based CHRISTUS Health has appointed Paul Trevino president and CEO of its Southeast Texas region, according to a Beaumont Enterprise report.
Akron, Ohio-based Summa Health System has eliminated the president position from Barberton Hospital and Wadsworth-Rittman Hospital, according to an Akron Beacon Journal report.
Detroit-based Henry Ford Health System lost $12 million in fiscal year 2013 as expenses outpaced revenue and admissions dropped systemwide.